Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
23.30
-0.64 (-2.67%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Aktis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $40 | Buy | Initiates | $40 | +71.67% | Sep 9, 2026 |
| Wedbush | Wedbush | Buy Initiates $35 | Buy | Initiates | $35 | +50.21% | Aug 19, 2026 |
| BMO Capital | BMO Capital | Buy Initiates $37 | Buy | Initiates | $37 | +58.80% | Aug 18, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +45.92% | Aug 14, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $33 | Buy | Reiterates | $33 | +41.63% | Aug 14, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 14, 2026 |
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +71.67% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +50.21% | Jun 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.